Clinical Trials Logo

BRCA1/2 clinical trials

View clinical trials related to BRCA1/2.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03396341 Recruiting - Genetic Testing Clinical Trials

Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations

Start date: January 4, 2018
Phase:
Study type: Observational

The purpose of this study is to describe how women with BRCA1/2 mutations react to genetic risk modifier testing, and to examine how they make decisions about their healthcare.